Herbal Anti-Migraine Balm Using Peppermint & Eucalyptus Oil

Authors

  • Naveen Rohiwal, Mr. Vipendra Singh, Dr. Kuldeep Patel

Keywords:

Herbal Migraine Balm, Peppermint Eucalyptus Relief, Natural Headache Remedy, Cooling Aromatherapy Salve, Essential Oil Pain Relief

Abstract

This study focuses on the formulation and evaluation of a herbal anti-migraine balm using natural essential oils, primarily peppermint oil and eucalyptus oil, known for their analgesic, anti-inflammatory, and soothing properties. Migraine is a neurological disorder characterized by severe headaches, often accompanied by nausea, sensitivity to light, and stress-related triggers. Conventional treatments may cause side effects with prolonged use, creating a need for safer, plant-based alternatives. The proposed herbal balm is prepared using a blend of peppermint oil (rich in menthol) and eucalyptus oil (containing eucalyptol), incorporated into a suitable base such as beeswax and carrier oils. Peppermint oil provides a cooling sensation that helps relax muscles and improve blood circulation, while eucalyptus oil exhibits anti-inflammatory and vasodilatory effects that aid in reducing headache intensity. The formulation is evaluated for parameters such as consistency, spreadability, stability, pH, and sensory characteristics. The balm demonstrates good physical stability, ease of application, and a pleasant aroma. Preliminary effectiveness studies indicate that topical application on the forehead and temples provides rapid relief from migraine symptoms by inducing a cooling effect and reducing tension. This herbal anti-migraine balm offers a safe, cost-effective, and natural alternative to synthetic medications, with minimal side effects and improved patient compliance.

References

GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024;23:344-81.Bron C, Sutherland HG, Grif iths LR (2021). "Exploring the Hereditary Nature of Migraine". Neuropsychiatric Disease and Treatment. 17: 1183–1194

Al-Karaghuli H, van den Maagdenberg A, Hansen TF, et al. Genetics of migraine: where are we now? J Headache Pain. 2023 Feb 20;24(1):12. doi: 10.1186/s10194-02301547-8.

Sturgeon JA, Ehde DM, Darnall BD, Barad MJ, Clauw DJ, Jensen MP. Psychological approaches for migraine management. Anesthesiol Clin. 2023 Jun;41(2):325-340. doi: 10.1016/j.anclin.2023.02.004.Li S, Liu Q, Ma M, Fang J, He L (17 April 2025). "Association between weather conditions and migraine: a systematic review and meta-analysis". Journal of Neurology. 272

Patel R, et al. Migraine Headache. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560787/International Headache Society (2018). 1.2.2 Migraine with brainstem aura. ICHD-3.

Lu Y, Chen J, Xu H, et al. The global and regional burden and trends of migraine from 1990 to 2021: indings from the Global Burden of Disease Study 2021. Front Neurol. 2025;16:1686288. doi:10.3389/fneur.2025.1686288.

Devoto M, Lozito A, Staffa G, D'Alessandro R, Sacquegna T, Romeo G. Segregation analysis of migraine in 128 families. Cephalalgia. 1986 Jun;6(2):101-5. doi: 10.1046/j.1468-2982.1986.0602101.x. PMID: 3723201.

Jen JC, Kim GW, Dudding KA, Baloh RW. No mutations in CACNA1A and ATP1A2 in probands with common types of migraine. Arch Neurol. 2004;61(8):1151-4. doi:10.1001/archneur.61.8.1151.

Ashina M, Buse DC, Lipton RB. Risk factors for migraine disease progression: a narrative review for clinicians. Headache. 2023 Oct;63(9):1435-1454. doi: 10.1111/head.14436.

Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Diener HC. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017 Apr;97(2):553-622. doi: 10.1152/physrev.00034.2015.

GBD 2023 Headache Disorders Collaborators. Global, regional, and national burden of headache disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurol. 2025. doi:10.1016/S1474-4422(25)00402-8.

Matsumori Y, Ueda K, Komori M, et al. Burden of migraine in Japan: results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Neurol Ther. 2022;11:79-97.

Lyu S, Lyu J, Huang X, et al. Ef icacy and Safety of Oral Chinese Herbal Medicine for Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Neurol. 2022;13:889336. doi:10.3389/fneur.2022.889336.

Göbel H, Schmidt G, Soyka D. Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia. 1994 Jun;14(3):228-34.

Yu H, Zhang Y, et al. Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil. Molecules. 2023;28(5):2234.

Yu H, Zhang Y, et al. Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil. Molecules. 2023;28(5):2234. doi:10.3390/molecules28052234.

Downloads

How to Cite

Naveen Rohiwal, Mr. Vipendra Singh, Dr. Kuldeep Patel. (2026). Herbal Anti-Migraine Balm Using Peppermint & Eucalyptus Oil. International Journal of Research & Technology, 14(2), 251–262. Retrieved from https://ijrt.org/j/article/view/1250

Issue

Section

Original Research Articles

Similar Articles

<< < 5 6 7 8 9 10 11 12 13 14 > >> 

You may also start an advanced similarity search for this article.